<SEC-DOCUMENT>0001193125-21-046513-index.html : 20210217 <SEC-HEADER>0001193125-21-046513.hdr.sgml : 20210217 <ACCEPTANCE-DATETIME>20210217161611 ACCESSION NUMBER: 0001193125-21-046513 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20210211 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 21644967 BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>d138536d8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: d138536d8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>d138536dex11.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: d138536dex11.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>d138536dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: d138536dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>d138536dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 4 - file: d138536dex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>5 <FILENAME>d138536dex992.htm <DESCRIPTION>EX-99.2 <TEXT> Document 5 - file: d138536dex992.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g138536g0215232140172.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g138536g0215232140172.jpg
</DOCUMENT> </SEC-DOCUMENT>